Impact of ABO blood group antigens on residual factor VIII levels and risk of inhibitor development in hemophilia A

BACKGROUND: The clinical phenotype of hemophilia A (HA) does not always correlate with severity. Similarly, the presence of inhibitors does not necessarily increase the risk of bleeding. This paradox between clinical and laboratory findings may be partially attributed to non-modifiable factors, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Debadrita, Kumar, Narender, Hans, Chander, Kler, Anita, Jain, Richa, Bansal, Deepak, Trehan, Amita, Jain, Arihant, Malhotra, Pankaj, Ahluwalia, Jasmina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063595/
https://www.ncbi.nlm.nih.gov/pubmed/36922445
http://dx.doi.org/10.5045/br.2023.2022197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063595/
https://www.ncbi.nlm.nih.gov/pubmed/36922445
http://dx.doi.org/10.5045/br.2023.2022197

Ejemplares similares